FIELD: organic chemistry; pharmaceutics.
SUBSTANCE: invention relates to bromine-containing sterically hindered phenols of formula Ia, Ib and Ic, where R is selected from (a) Me, (b) Et and (c) Ph. Invention also relates to the use of a compound of formula I as an agent having anticancer activity.
EFFECT: anticancer compounds of formula I, capable of effectively leading to apoptosis along the internal mitochondrial pathway, thereby inhibiting the growth of cancer cells.
2 cl, 4 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
| PHOSPHONIUM SALTS BASED ON ALANTOLACTONE, HAVING ANTI-TUMOUR ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818095C1 |
| FLUORINE-CONTAINING BENZYLATED ISATINS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802016C1 |
| FLUORINE-CONTAINING BENZYLATED ISATINS | 2023 |
|
RU2816105C1 |
| SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
| ANTITUMOR AGENTS BASED ON MACRO- AND MICROELEMENT-CONTAINING POLYGALACTURONATES (OPTIONS) | 2022 |
|
RU2792613C1 |
| PINANE C,N-PALLADACYCLES CONTAINING L-AMINO ACIDS AND THEIR USE AS ANTITUMOR AGENTS | 2022 |
|
RU2799205C1 |
| PYRIDOXIN AND ACETONE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2017 |
|
RU2639879C1 |
| AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814259C1 |
| AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
